|
CN111620879A
|
|
PF-06651600 maleate, crystal form and preparation method thereof
|
|
CN111732591A
|
|
PF-06651600L-tartrate, crystal form and preparation method thereof
|
|
CN111620880A
|
|
PF-06651600 DL-tartrate, crystal form and preparation method thereof
|
|
CN111450072A
|
|
Ticagrelor controlled release tablet and preparation method thereof
|
|
CN111650290A
|
|
Analysis method of tenofovir alafenamide hemifumarate related substances
|
|
CN111650289A
|
|
Method for determining related substances of 3-chloro-1- (N, N-dimethyl) propylamine hydrochloride
|
|
CN111650288A
|
|
Method for detecting (R) -3-tert-butyloxycarbonylaminopiperidine enantiomer
|
|
CN111407738A
|
|
Brivaracetam controlled-release preparation and preparation method thereof
|
|
CN111643448A
|
|
Moxifloxacin hydrochloride ophthalmic gel and preparation method thereof
|
|
CN111298134A
|
|
Rupatadine fumarate solid preparation composition and preparation method thereof
|
|
CN111184696A
|
|
Tofacitinib citrate sustained-release tablet and preparation method thereof
|
|
CN111202714A
|
|
Faropenem sodium particles and preparation method thereof
|
|
CN111110634A
|
|
Chloroquine phosphate inhalation aerosol and preparation method thereof
|
|
CN111265499A
|
|
Lopinavir inhalation aerosol and preparation method thereof
|
|
CN111202724A
|
|
Arbidol inhalation dry powder pharmaceutical composition and preparation method thereof
|
|
CN111202723A
|
|
Darunavir inhalation dry powder pharmaceutical composition and preparation method thereof
|
|
CN111202722A
|
|
Lopinavir inhalation dry powder pharmaceutical composition and preparation method thereof
|
|
CN111320569A
|
|
Preparation method of pimavanserin solid intermediate
|
|
CN107573292A
|
|
Act on the pyrazine derivative compound of prolyl hydroxylase
|
|
CN107417605A
|
|
Act on the pyridine derivative compound of prolyl hydroxylase
|
